Objective: To assess the effect of reproductive factors, especially hormonal replacement therapy (HRT) and its interaction with HLA-DRB1 *01 and/or *04 alleles on the diagnosis of RA and the presence of anti-CCP in women included in the ESPOIR cohort (early arthritis cohort).
Methods: 568 patients were included in the analyses. Analyses were performed using logistic regression.
Results: HRT would reduce the risk for RA due to the HLA-DRB1 *01 and/or *04 alleles: from OR=1.88 (95%CI 1.32-2.68, p<0.000) for HLA-DRB1 *01 and/or *04 alleles alone to OR=1.07 (0.51-2.26, p=0.85) in women who carry HLA-DRB1 *01 and/or *04 alleles and who received a HRT. One explanation would be the protective effect of HRT on the presence of anti-CCP (OR=0.43, 95%CI 0.24-0.77, p<0.006). Other reproductive factors such as the number of pregnancies, menopause, and age of the menopause, age of the menarche and a history of pregnancy with poor outcome were not associated with the diagnosis of RA and the presence of anti-CCP.
Conclusion: HRT may reduce the risk of RA due to HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.